Overview

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Overactive bladder is a common problem among adult women. Darifenacin is an antimuscarinic drug that is frequently used as part of the management of the condition. However, current evidence backing its use is limited. This study aims to address Darifenacin's effectiveness in adjunct to physiotherapy in treating symptoms due to overactive bladder.
Phase:
Phase 3
Details
Lead Sponsor:
Universidad de Valparaiso
Collaborator:
Recalcine (GynoPharm)
Treatments:
Darifenacin